Market Overview:
The global Betamethasone ointment market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The Betamethasone ointment market is segmented on the basis of type, application and region. On the basis of type, the Betamethasone dipropionate segment is expected to account for a major share in terms of revenue in 2018 and is projected to register a CAGR of 5.8% during the forecast period. The betamethasone sodium phosphate segment is projected to grow at a higher rate as compared to other segments during the forecast period owing to its high efficacy in treating various skin conditions such as psoriasis, eczema and dermatitis. On the basis of application, hospitals are estimated to account for majority share in terms revenue generated by Betamethasone ointment market in 2018 and this trend is anticipated continue throughout 2030 owing rising prevalence rates for various skin diseases across globe coupled with increasing number os hospital admissions globally .
Product Definition:
Betamethasone ointment is a topical corticosteroid used to treat inflammation and itching. It is important because it can help relieve symptoms and improve the appearance of the skin.
Betamethasone Dipropionate:
Betamethasone dipropionate is a synthetic glucocorticoid from the betamethasone family. It is used as an anti-inflammatory drug and for the treatment of corticosteroid- responsive dermatoses such as xerosis/xerochondritis, psoriasis, and acne rosacea.
Betamethasone Sodium Phosphate:
Betamethasone sodium phosphate is a prescription drug used to treat skin conditions such as psoriasis. It works by reducing the production of cytokines (immune proteins) that cause inflammation. Betamethasone sodium phosphate topical ointment is prescribed for people with moderate to severe plaque psoriasis, who are not responding well to conventional treatment options.
Application Insights:
The others segment held the largest share of the global market in 2017. This segment includes veterinary applications, such as horses and dogs. Betamethasone ointment is used for treating skin conditions, such as atopic dermatitis (AD) and contact eczema, in animals. The rising prevalence of AD among humans may also contribute to the growth of this segment over the forecast period.
The hospital application segment accounted for a significant share in 2017 due largelyto increasing usage rates of corticosteroids by hospitals across various regions including North America.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position throughout the forecast period owing to rising healthcare expenditure and increasing awareness about various treatment options available for skin conditions. In addition, high adoption of new generation drugs in this region is also contributing towards growth.
Asia Pacific is anticipated to witness significant growth over the forecast period owing to rising disposable income and improving healthcare infrastructure in emerging countries such as China, India, South Korea & Japan (CIKD). Furthermore, increasing prevalence of atopic dermatitis among children & adolescents are some other factors that are likely to contribute towards market growth during the forecast period. Betamethasone dipropionate was observed most commonly while Valerate was least used product type across Asia Pacific; however Valerate accounted for a larger share of betamethasone sodium phosphate prescriptions compared with Dipropionate across all age groups except pediatric patients aged 12 years and above (12%).
Growth Factors:
- Increasing incidence of skin diseases: The Betamethasone Ointment market is driven by the increasing incidence of skin diseases. According to a study by the World Health Organization, over 1 billion people are affected by some form of skin disease, which is expected to rise in the coming years. This will create demand for Betamethasone Ointment products and drive market growth.
- Rising awareness about skin care: There has been a rising awareness among people about the importance of taking care of their skin and this is driving demand for Betamethasone Ointment products. People are becoming more aware of the benefits offered by these products and are increasingly using them to take care of their skin health.
- Growing aging population: The global aging population is growing at a rapid pace and this is creating demand for better skincare solutions, including Betamethasone Ointment products. As people age, they become more susceptible to various types of skin problems and thus require specialized skincare solutions like those offered by Betamethasone Ointment manufacturers/suppliers .
Scope Of The Report
Report Attributes
Report Details
Report Title
Betamethasone Ointment Market Research Report
By Type
Betamethasone Dipropionate, Betamethasone Sodium Phosphate, Betamethasone Valerate
By Application
Hospital, Clinic, Others
By Companies
GlaxoSmithKline, East West Pharma, Omega Remedies, Moraceae Pharmaceuticals, Emson Medichem, Dermocare Laboratories, Cipla, Micro Labs, Pharmtak Ophtalmics, Psyco Remedies, GlaxoSmithKline
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
148
Number of Tables & Figures
104
Customization Available
Yes, the report can be customized as per your need.
Global Betamethasone Ointment Market Report Segments:
The global Betamethasone Ointment market is segmented on the basis of:
Types
Betamethasone Dipropionate, Betamethasone Sodium Phosphate, Betamethasone Valerate
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GlaxoSmithKline
- East West Pharma
- Omega Remedies
- Moraceae Pharmaceuticals
- Emson Medichem
- Dermocare Laboratories
- Cipla
- Micro Labs
- Pharmtak Ophtalmics
- Psyco Remedies
- GlaxoSmithKline
Highlights of The Betamethasone Ointment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Betamethasone Dipropionate
- Betamethasone Sodium Phosphate
- Betamethasone Valerate
- By Application:
- Hospital
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Betamethasone Ointment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Betamethasone ointment is a topical corticosteroid medication used to treat various skin conditions. It is available as a cream, lotion, or aerosol spray. Betamethasone ointment is typically applied to the skin once daily and can be used for long-term treatment of certain skin conditions such as eczema or psoriasis.
Some of the major companies in the betamethasone ointment market are GlaxoSmithKline, East West Pharma, Omega Remedies, Moraceae Pharmaceuticals, Emson Medichem, Dermocare Laboratories, Cipla, Micro Labs, Pharmtak Ophtalmics, Psyco Remedies, GlaxoSmithKline.
The betamethasone ointment market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Betamethasone Ointment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Betamethasone Ointment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Betamethasone Ointment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Betamethasone Ointment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Betamethasone Ointment Market Size & Forecast, 2020-2028
4.5.1 Betamethasone Ointment Market Size and Y-o-Y Growth
4.5.2 Betamethasone Ointment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Betamethasone Dipropionate
5.2.2 Betamethasone Sodium Phosphate
5.2.3 Betamethasone Valerate
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Betamethasone Ointment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Betamethasone Ointment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Betamethasone Dipropionate
9.6.2 Betamethasone Sodium Phosphate
9.6.3 Betamethasone Valerate
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Betamethasone Dipropionate
10.6.2 Betamethasone Sodium Phosphate
10.6.3 Betamethasone Valerate
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Betamethasone Dipropionate
11.6.2 Betamethasone Sodium Phosphate
11.6.3 Betamethasone Valerate
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Betamethasone Dipropionate
12.6.2 Betamethasone Sodium Phosphate
12.6.3 Betamethasone Valerate
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Betamethasone Dipropionate
13.6.2 Betamethasone Sodium Phosphate
13.6.3 Betamethasone Valerate
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Betamethasone Ointment Market: Competitive Dashboard
14.2 Global Betamethasone Ointment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GlaxoSmithKline
14.3.2 East West Pharma
14.3.3 Omega Remedies
14.3.4 Moraceae Pharmaceuticals
14.3.5 Emson Medichem
14.3.6 Dermocare Laboratories
14.3.7 Cipla
14.3.8 Micro Labs
14.3.9 Pharmtak Ophtalmics
14.3.10 Psyco Remedies
14.3.11 GlaxoSmithKline
